Results 121 to 130 of about 7,882 (188)

Matching-adjusted indirect comparison analysis of omalizumab versus dupilumab in patients with chronic spontaneous urticaria. [PDF]

J Allergy Clin Immunol Glob
Mosnaim G, Seetasith A, Holden M, Trzaskoma BL, Saini SS.   +4 more
europepmc   +1 more source

Integrated Transcriptomic Analysis Unveils Hub Genes and Immune Dysregulation in Chronic Spontaneous Urticaria Pathogenesis. [PDF]

J Inflamm Res
Wen X, Zhang J.
europepmc   +1 more source

Systemic lupus erythematosus comorbid with chronic spontaneous urticaria: a multicentre retrospective study. [PDF]

Lupus Sci Med
Zeng X, Xu H, Li Q, Wei S, Lin N, Yin L, Zhu J, Yang S, Tang Y, Liang G, Lai W, Zhang W, Lai K.   +12 more
europepmc   +1 more source

Expanding treatment options in chronic spontaneous urticaria: the emerging role of dupilumab. [PDF]

Ann Med Surg (Lond)
Fathima Haseena H, Kumari S, Jaber Amin MH.   +2 more
europepmc   +1 more source

The burden of chronic spontaneous urticaria in Europe: Call for action. [PDF]

J Eur Acad Dermatol Venereol
Kocatürk E, Thomsen SF.
europepmc   +1 more source

Advances in Pathophysiology and Therapeutic Paradigm Shifts in Chronic Spontaneous Urticaria: A Narrative Review. [PDF]

Dermatol Ther (Heidelb)
Kim HB, Um JY, Chung BY, Park CW, Kim HO.   +4 more
europepmc   +1 more source

Remibrutinib Showed a Favorable Safety Profile and Sustained Efficacy in Japanese Patients with Chronic Spontaneous Urticaria Over 52 Weeks. [PDF]

Dermatol Ther (Heidelb)
Hayama K, Chinuki Y, Yagami A, Kume A, Morita A, Miyazu S, Lheritier K, Jaskiewicz L, Haemmerle S, Hide M.   +9 more
europepmc   +1 more source

Anti-KIT Barzolvolimab for Chronic Spontaneous Urticaria. [PDF]

Allergy
Maurer M, Metz M, Anderson J, Talreja N, Young D, Crowley E, Heath-Chiozzi M, Ma R, Paradise E, Hawthorne T, Alvarado D, Bernstein JA.   +11 more
europepmc   +1 more source